Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hospital-to-Home transitional cardiac rehabilitation as a transition from Centre-Based cardiac rehabilitation after cardiac surgery: a Single-Blind randomised controlled trial

NCT ID NCT07811102

NEW Sponsor: Cheng-Hsin General Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 · Last updated Sep 09, 2026

Summary

Cardiac rehabilitation (CR) improves outcomes after cardiac surgery, but is usually delivered on a fixed centre-based schedule that requires repeated daytime hospital attendance. A hybrid model, in which supervised training begins in hospital and then transitions to monitored home-based training, may make the service reachable for more patients without reducing supervision during the early postoperative period. This single-blind randomised controlled trial compared a hospital-to-home transitional (hybrid) CR programme with conventional centre-based CR in adults at low exercise-training risk after cardiac surgery. Participants were allocated 1:1. Control participants attended twice weekly for 8 weeks (16 supervised sessions). Hybrid participants attended twice weekly for 2 weeks (4 supervised sessions), underwent a repeat risk assessment, and then trained at home for 6 weeks with heart-rate monitoring, a cloud-based care platform, weekly telephone contact and twice-weekly text messages. The primary outcome was peak oxygen uptake measured by cardiopulmonary exercise testing at baseline and 8 weeks. The trial was designed as a pilot study to estimate treatment effect and variability for a future definitive trial.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Jun 2023

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * Aged 20 to 75 years. * Admitted to the department of cardiovascular surgery and undergoing cardiac surgery during the index admission. * Meeting the indications for cardiac rehabilitation. * Classified as low risk (Class B) for exercise training according to the 2013 American Heart Association exercise standards, that is, clinically stable coronary artery disease, valvular heart disease, congenital heart disease, cardiomyopathy, or an abnormal exercise test not reaching high-risk criteria. * Able to self-monitor exercise intensity. Exclusion Criteria * An irreversible condition causing exercise intolerance or limiting exercise capacity. * Persistent atrial fibrillation or non-sustained ventricular tachycardia within the preceding six months, an implanted defibrillator, or any other rhythm that could compromise the reliability of home heart-rate recording. * Hypertrophic cardiomyopathy or recent myocarditis. * New York Heart Association class III or IV; angina or ischaemic electrocardiographic change during moderate-intensity exercise; a fall in systolic blood pressure during exercise; non-sustained ventricular tachycardia; previous cardiac arrest; or any condition judged by the physician to be potentially life-threatening. * During the study, reported adverse symptoms or escalation of exercise-training risk to Class C or D, including suspected angina, abnormal dyspnoea, vomiting or syncope, or an emergency department visit or readmission. * Unable to operate the communication and exercise applications independently. * Declined to take part in testing.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac rehabilitation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder heart valve disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac rehabilitation Cardiac surgical procedures Coronary artery disease Heart valve diseases Telerehabilitation

Contacts and locations

Locations

  • Cheng Hsin General Hospital

    Taipei, 11220, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.